Polpharma is a major manufacturer of pharmaceuti
The Starogard Gdanski facility is one of the largest and most modern drug manufacturing plants in Europe. Here Polpharma manufactures a wide variety of products and forms:
Solid forms include tablets, film-coated tablets, effervescent tablets, sugar coated tablets, and capsules. The annual manufacturing capacity of solid forms is 6 billion units.
Parenteral drugs include injectable preparations in polyethylene packaging and glass ampoulesCONTROL ENGINEERING China版权所有, single- and multi-dose eye drops, nasal drops, infusion fluidsCONTROL ENGINEERING China版权所有, and fluids for external use. In 2005, the company started up a new ampoule filling facility, constructed in compliance with strict GMP (good manufacturing practice) standards for sterile manufacturing.
Active pharmaceutical ingredients (API), with reactor capacity of 320控制工程网版权所有,000 liters. API manufacturing facilities are regularly audited by the FDA.
All manufacturing units in the plant have GMP certificates issued by the Main Pharmaceutical Inspectorate and PIC/S (Pharmaceutical Inspection Cooperation Scheme). Polpharma also offers contract manufacturing services of both drug products and active pharmaceutical ingredients.
Polpharma has used Honeywell


在线会议
论坛
专题
工控直播
新闻中心
子站
技术
社区


中控时间序列大模型TPT免费有奖体验
爱德克SE2L进阶版安全激光扫描仪有奖预约演示
剑维软件电子半导体行业白皮书有奖下载
魏德米勒麒麟系列产品赋能本土工业
Fluke 283 FC 智能万用表震撼来袭





















